Board brings together internationally recognized leaders in immunology, oncology, and translational science to guide next-gen immune-engineering platforms. FORT LAUDERDALE, FL, UNITED STATES, December ...

ARK also increased its stake in Twist Bioscience Corp (NASDAQ:TWST) by acquiring 32,709 shares, totaling $1,051,594, through ARKK and ARKG ETFs. This follows a purchase of 50,963 shares of Twist just ...

The latest announcement is out from Lixte Biotechnology Holdings ( ($LIXT) ). On December 30, 2025, Lixte Biotechnology Holdings, Inc. entered ...

Puma Biotechnology (PBYI) relies on one product. It has weak fundamentals and has struggled to grow sales. ・PBYI stock has ...

Participants in the program via the Indiana Life Sciences Association can receive significant discounts—up to 75%—off list ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

Nevada ranchers will have multiple opportunities this January to hear directly from university specialists, veterinarians, ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

An FDA decision will extend the timeline for possible approval of Inovio's lead new drug candidate, a therapy that could ...

U.S. policy, China’s strategic rise, blockbuster deals and AI dominated South Korea’s biotechnology industry this year, with U.S. tariffs and the Biosecure Act’s hitch onto 2026 legislation serving as ...

Two phase III studies of setrusumab, Orbit and Cosmic, for treating brittle bones have failed and left the developers floundering on Wall Street. Neither of Ultragenyx Pharmaceutical Inc. and Mereo ...